Jesse Smedley is a Principal of Oakbridge Insurance and the founder of iHealthBrokers. He founded iHealthBrokers in 2007, and Oakbridge acquired iHealthBrokers in 2025. He has spent nearly two decades teaching people how to save money on their health insurance and navigate Medicare, and he is the author of Medicare A to Z: Your Roadmap to Medicare.
There’s big news in the world of Medicare. On July 1, 2026, Medicare launched the Medicare GLP-1 Bridge.
The big promise? Eligible Medicare beneficiaries can get certain GLP-1 weight-loss drugs for $50 a month. Compared with list prices of roughly $1,000 or more a month, that’s a huge savings.
But despite what you may have heard, not everyone qualifies, and not every GLP-1 is included. Prior authorization is required, and the program is temporary. There are also open questions about how it could affect future Medicare premiums, long-term costs and Part D rules.
What Has Actually Changed?
By law, Medicare Part D generally can’t cover drugs prescribed only for weight loss. That’s why Medicare has historically not covered GLP-1 drugs for obesity alone.
There are exceptions. Part D plans can cover GLP-1 drugs for other medically accepted uses, such as type 2 diabetes, reducing cardiovascular risk and obstructive sleep apnea. So some beneficiaries already have coverage for drugs like Ozempic, Mounjaro, Wegovy or Zepbound because of a covered medical condition.
What Is the Medicare GLP-1 Bridge?
CMS announced the Medicare GLP-1 Bridge in May 2026. It’s called a “bridge” because it’s a temporary program meant to fill the gap until a larger, longer-term approach (CMS’s BALANCE Model) is in place.
It’s important to understand that this is not Congress changing Medicare law. It’s a CMS demonstration that tests broader coverage of obesity drugs.
Timeline and Why Medicare Is Testing It
The Bridge started July 1, 2026, and is scheduled to run through December 31, 2027. It isn’t permanent. It’s designed to test how this kind of coverage works and, maybe most importantly, what it costs.
The Part D portion of the BALANCE Model was originally expected to start in January 2027, but CMS delayed it in April 2026, and no new start date has been set. That’s why the Bridge now runs through the end of 2027. There’s no guarantee of what replaces it after that.
Medicare has held off on covering weight-loss drugs largely because of the potential long-term cost. Estimates for the Bridge alone vary widely depending on how many people use it, so Medicare is studying the financial impact before any permanent change.
Will This Increase Medicare Premiums?
The big question is: who pays for these expensive drugs?
The Bridge works differently from your normal Part D coverage. You must have a Part D plan or a Medicare Advantage plan with drug coverage to use it, but CMS processes and pays these claims through a central system rather than through your plan’s normal benefit. The $50 payments also don’t count toward your Part D deductible or yearly out-of-pocket limit.
CMS hasn’t said the Bridge will raise Part B or Part D premiums. The long-term picture is less clear. If coverage becomes permanent, premiums, out-of-pocket costs, formularies and prior authorization rules could all change. We don’t know yet.
Which GLP-1 Drugs Are Covered?
Only three drugs are included in the Bridge:
- Wegovy (semaglutide), injection and pill
- Zepbound KwikPen (tirzepatide)
- Foundayo (orforglipron)
The same active ingredient is often sold under different brand names. Semaglutide is sold as Ozempic (for diabetes) and Wegovy (for weight management). Tirzepatide is sold as Mounjaro (for diabetes) and Zepbound (for weight management and sleep apnea). Ozempic and Mounjaro are not part of the Bridge.
This is why your diagnosis matters so much. Medicare covers the use, not just the drug. Two people taking essentially the same medication can pay very different amounts depending on their diagnosis, how the prescription is billed and whether they qualify for the Bridge. Expect some confusion and frustration while everyone learns the rules.
Who Actually Qualifies?
First, you must be enrolled in a Part D plan or a Medicare Advantage plan with drug coverage.
Second, you must meet the medical criteria. You need to have obesity or be overweight, plus one of the following:
- A BMI of 35 or higher
- A BMI of 30 or higher with heart failure, uncontrolled high blood pressure or kidney disease
- A BMI of 27 or higher with prediabetes, a previous heart attack or stroke, or peripheral artery disease
The Bridge is for people who can’t already get a GLP-1 covered through their regular Part D benefit. If you have type 2 diabetes, moderate to severe sleep apnea or certain liver disease, your coverage generally goes through your Part D plan instead.
Your doctor must submit a prior authorization request, and it has to confirm you’ve received counseling on lifestyle changes like diet and exercise.
The Fine Print
- Eligible participants pay $50 for a monthly supply.
- The $50 payments do not count toward your Part D deductible or the $2,100 Part D out-of-pocket limit for 2026.
- Extra Help can’t lower the $50, and manufacturer coupons can’t be applied.
That matters because many people will assume these copays help them meet their deductible or reach the out-of-pocket cap. They don’t.
If you’re interested, talk to your doctor, know your BMI and review your health history. Check your current drug coverage, and keep an eye on CMS updates as the rules continue to evolve.
What This Could Mean Down the Road
CMS has suggested that future GLP-1 coverage may depend on which Medicare plans choose to participate. That could make your choice of Part D or Medicare Advantage plan more important than ever.
And while the Bridge offers big savings to people who take these drugs, the money has to come from somewhere. How these costs could eventually show up for beneficiaries is still unknown. If you’re new to Medicare, our Medicare 101 webinar is a good place to start.
Get Help With Your Drug Coverage
Wondering whether your plan works with the GLP-1 Bridge, or whether a different Part D plan makes more sense? Our licensed brokers can help at no cost. Get your free quote or call us at (866) 260-9829.
